Ngā hua rapu - Florinda Santos
- E whakaatu ana i te 1 - 7 hua o te 7
-
1
Imatinib-Induced Bone Edema: Case Report and Review of Literature mā Lucas Vieira dos Santos, João Paulo da Silveira Nogueira Lima, Kathia Cristina Abdalla, Arinilda Bragagnoli, Florinda Santos, Alexandre A. Jácome, Fabiano Elias Porto
I whakaputaina 2013Revisão -
2
Accuracy and Clinical Relevance of Intra-Tumoral Fusobacterium nucleatum Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR) in Colorectal Ca... mā José Guilherme Datorre, Ana Carolina de Carvalho, Mariana Bisarro dos Reis, Monise dos Reis, Marcus Matsushita, Florinda Santos, Denise Peixoto Guimarães, Rui Manuel Reis
I whakaputaina 2022Artigo -
3
Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay mā Mariana Bisarro dos Reis, Wellington dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarães
I whakaputaina 2024Pré-impressão -
4
Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay mā Mariana Bisarro dos Reis, Wellington dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarães
I whakaputaina 2024Artigo -
5
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial mā Arinilda Bragagnoli, Raphael L. C. Araújo, Maurício Wagner Souto Ferraz, Lucas Vieira dos Santos, Kathia Cristina Abdalla, Fabiana Comar, Florinda Santos, Marco Antônio de Oliveira, José Barreto Campello Carvalheira, Flavio Mavignier Cárcano, João Paulo da Silveira Nogueira Lima
I whakaputaina 2021Artigo -
6
Association of Genetic Ancestry and Colorectal Cancer Risk in a Large Brazilian Cohort: Replication of Single-Nucleotide Polymorphisms Identified by Genome-Wide Association Studies mā Ana Carolina de Carvalho, Ana Carolina Laus, Adeylson Guimarães Ribeiro, Jun Porto, Débora Sant'Anna, Denise Peixoto Guimarães, José Guilherme Datorre, Rosielly Melo Tavares, Antônio Carlos, Tulio Furquim, Miyuki Uno, Roger Chammas, Priscilla Marqui Schmidt Villela, Rui Manuel Reis, Marcus Matsushita, Marco Antônio de Oliveira, Welinton Yoshio Hirai, Denise Peixoto Guimarães, Florinda Santos, Rui Manuel Reis
I whakaputaina 2025Artigo -
7
1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab ± bevacizumab + TACE in participants with embolization-eligible unresectable hepato... mā Stephen L. Chan, Masatoshi Kudo, Thomas Decaens, Joseph P. Erinjeri, Shukui Qin, Zhenggang Ren, Yasuaki Arai, Mohamed Bouattour, В. В. Бредер, Shi-Ming Lin, Jeong Heo, Jean‐Marie Péron, Vincenzo Mazzaferro, Quang T. Nguyen, Joong‐Won Park, Lünan Yan, Alejandro Molina Alavez, Chang-Fang Chiu, Kwong‐Ming Kee, Florinda Santos, Aibing Xu, Anil Veluvolu, Yoshitaka Inaba, Satheesh Chiradoni Thungappa, Farshid Dayyani, David Hsieh, Vaidehi Dave, Claire Morgan, Kerry Parsons, Mallory Makowsky, Riccardo Lencioni, Bruno Sangro
I whakaputaina 2024Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Cancer
Oncology
Colorectal cancer
Biology
Gene
Genetics
Cancer research
Gastroenterology
Mutation
Pathology
Surgery
Adverse effect
Astrobiology
Bevacizumab
Biomarker
Carcinogenesis
Case-control study
Chemotherapy
Clinical endpoint
Clinical significance
Clinical trial
Digital polymerase chain reaction
Disease
Durvalumab
Edema
Embolization
Environmental health
Fusobacterium nucleatum